DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Published on July 28, 2021
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )
| Filed by the Registrant x | ||
| Filed by a Party other than the Registrant ¨ | ||
| Check the appropriate box: | ||
| ¨ | Preliminary Proxy Statement | |
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ¨ | Definitive Proxy Statement | |
| x | Definitive Additional Materials | |
| ¨ | Soliciting Material under §240.14a-12 | |
| Trevena, Inc. | ||
| (Name of Registrant as Specified in Its Charter) | ||
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||
| Payment of Filing Fee (Check the appropriate box): | ||
| x | No fee required. | |
| ¨ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |
| (1) | Title of each class of securities to which transaction applies: | |
| (2) | Aggregate number of securities to which transaction applies: | |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
| (4) | Proposed maximum aggregate value of transaction: | |
| (5) | Total fee paid: | |
| ¨ | Fee paid previously with preliminary materials. | |
| ¨ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |
| (1) | Amount Previously Paid: | |
| (2) | Form, Schedule or Registration Statement No.: | |
| (3) | Filing Party: | |
| (4) | Date Filed: | |
Dear Trevena Stockholder:
We are excited by Trevena’s prospects and are asking for your support for the proposals at our Special Meeting of Stockholders: a reverse split of our common stock and a reduction in authorized shares.
Our Board believes these proposals are in the best interest of our shareholders and recommends a vote FOR the proposals. Glass Lewis and ISS, two leading independent shareholder advisory services, also recommend a vote FOR the proposals.
After a transformational year, Trevena was added to the Russell 2000® index of leading small-cap companies. The proposals position us well for long term growth:
| - | Aligns Share Count. The median Russell 2000 company has ~40M shares outstanding, and Trevena would have ~41M post-split |
| - | Facilitates Institutional / Individual Investors. Intended to eliminate price-based restrictions and reduce transaction costs |
| - | Provides Financial Flexibility. Enables Trevena to move quickly, should the opportunity arise, on a range of fronts |
| o | Expand into new areas for OLINVYK beyond initial launch focus |
| o | Act on strategic opportunities that may improve scale and leverage commercial field force |
| o | Advance pipeline assets upon positive data, including TRV027 (COVID-19 studies with NIH ACTIV-4 Host Tissue and REMAP-CAP); TRV045 (diabetic neuropathic pain); TRV734 (opioid use disorder) and TRV250 (migraine) |
YOUR PARTICIPATION IS IMPORTANT – PLEASE VOTE TODAY!
According to our latest records, your proxy vote relating to this Special Meeting of Stockholders has not yet been received.
Please take a moment to refer to the enclosed Vote Instruction Form to vote your shares. You may also call a representative to assist you toll-free:
833-501-4709
Sincerely,
Carrie L. Bourdow
President and Chief Executive Officer